Vault-13

AJU IB Investment Co., Ltd.

Seoul, M5 · CIK 1710065 · 13F filing filed 2022-08-09

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$51.6m reported value -20.2% vs Q1 2022
7positions
100.0%in top 10
0 new 0 added 0 reduced 0 sold out vs Q1 2022

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ARCELLX INC COMMON STOCK ACLX ACLX 1,380,890 $25.0m48.34% 48.34% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 1.4m, Q2 2022 1.4m
2 KYMERA THERAPEUTICS INC COM KYMR KYMR 457,059 $9.0m17.42% 17.42% UnchangedShares held: Q3 2021 639.1k, Q4 2021 457.1k, Q1 2022 457.1k, Q2 2022 457.1k
3 SEER INC COM CL A SEER SEER 816,375 $7.3m14.15% 14.15% UnchangedShares held: Q3 2021 816.4k, Q4 2021 816.4k, Q1 2022 816.4k, Q2 2022 816.4k
4 RALLYBIO CORP COM COM 754,678 $5.7m11.03% 11.03% UnchangedShares held: Q3 2021 0, Q4 2021 754.7k, Q1 2022 754.7k, Q2 2022 754.7k
5 XILIO THERAPEUTICS INC COM COM 667,742 $1.9m3.78% 3.78% UnchangedShares held: Q3 2021 0, Q4 2021 667.7k, Q1 2022 667.7k, Q2 2022 667.7k
6 RAPT THERAPEUTICS INC COM COM 99,503 $1.8m3.52% 3.52% UnchangedShares held: Q3 2021 99.5k, Q4 2021 99.5k, Q1 2022 99.5k, Q2 2022 99.5k
7 SUTRO BIOPHARMA INC COM COM 175,000 $912.0k1.77% 1.77% UnchangedShares held: Q3 2021 175.0k, Q4 2021 175.0k, Q1 2022 175.0k, Q2 2022 175.0k